Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Bernard Leick, M.D.

Concepts (107)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive20202412852.290 Why?
Hematologic Neoplasms4202218220.940 Why?
Graft vs Host Disease3202229180.930 Why?
Receptors, Antigen, T-Cell7202425480.890 Why?
Pulmonary Alveolar Proteinosis12022420.830 Why?
Hematopoietic Stem Cell Transplantation4202353990.710 Why?
Hematologic Diseases220234940.700 Why?
Communication Barriers120203970.590 Why?
Professional-Family Relations120204830.550 Why?
Leukemia, Myeloid, Acute3202234870.530 Why?
Lymphoma, B-Cell120209350.470 Why?
fms-Like Tyrosine Kinase 3120174790.460 Why?
T-Lymphocytes132023101770.360 Why?
Neurotoxicity Syndromes220232910.320 Why?
Lymphohistiocytosis, Hemophagocytic220232600.310 Why?
Physician-Patient Relations1202032270.290 Why?
Communication1202037500.280 Why?
Glioblastoma4202434560.270 Why?
Molecular Targeted Therapy1201727110.260 Why?
Interleukin-7120231420.220 Why?
Transplantation Conditioning2202015790.220 Why?
Central Nervous System Neoplasms220228930.210 Why?
Lymphoma2202218820.200 Why?
Protein Kinase Inhibitors1201755060.190 Why?
Interleukin 1 Receptor Antagonist Protein120222960.180 Why?
Hospital Departments120201370.180 Why?
Translating120201440.170 Why?
Pancytopenia120191020.160 Why?
Antineoplastic Agents22023136470.160 Why?
Cyclophosphamide2202322370.150 Why?
Lentivirus120205030.150 Why?
Lymphoma, T-Cell, Cutaneous120192070.150 Why?
Transduction, Genetic120209050.150 Why?
Neoplasms32023216700.150 Why?
Antibodies, Bispecific120191630.150 Why?
Humans3220247435210.150 Why?
Telephone120206160.140 Why?
Antigen-Presenting Cells120209690.140 Why?
Tandem Repeat Sequences120171840.140 Why?
Ubiquitin-Protein Ligases1202318540.120 Why?
Lymphoma, Non-Hodgkin1202113820.120 Why?
Autoantibodies1202220420.120 Why?
Drug Approval120207770.120 Why?
Gene Expression Regulation, Leukemic120176460.110 Why?
Biological Products120228580.110 Why?
United States Food and Drug Administration1202015970.110 Why?
Lymphoma, Large B-Cell, Diffuse1202213790.110 Why?
Bone Marrow Transplantation1201927390.100 Why?
Antigens, Neoplasm1201919940.100 Why?
Organoplatinum Compounds120124070.100 Why?
Hodgkin Disease1201914150.090 Why?
Antigens, CD19220223900.090 Why?
Intensive Care Units1202036730.070 Why?
Skin1201943680.070 Why?
Neoplasm Staging12020110180.070 Why?
Antibodies, Monoclonal1202392590.070 Why?
Multiple Myeloma1202351720.070 Why?
Combined Modality Therapy1201786320.060 Why?
Antineoplastic Combined Chemotherapy Protocols22017114990.060 Why?
Disease Progression12020132490.060 Why?
Cytokines3202373330.050 Why?
Drug Resistance, Neoplasm1201751500.050 Why?
France120235110.050 Why?
Clinical Trials as Topic1201779010.050 Why?
Antibodies, Viral2202231620.050 Why?
Ubiquitination1202310060.040 Why?
Macrophage Activation120225640.040 Why?
Codon, Nonsense120192790.040 Why?
Brain Neoplasms1201988100.040 Why?
Liver Neoplasms1201242500.040 Why?
Cell Death1202216980.030 Why?
United States22023698340.030 Why?
Transforming Growth Factor beta1202320000.030 Why?
Leukocytes, Mononuclear1202218390.030 Why?
Cell Line, Tumor22023166180.030 Why?
Adult520232138700.030 Why?
Child22023775770.030 Why?
Neoplasm Recurrence, Local2202492360.030 Why?
Exanthema120195010.030 Why?
Fatal Outcome1201918540.030 Why?
Treatment Outcome22019631050.030 Why?
Retrospective Studies22019774570.030 Why?
Signal Transduction12017233540.030 Why?
Neoplasms, Experimental1201912760.030 Why?
Interferon-gamma1202232140.030 Why?
Mutation12017297010.030 Why?
Infusions, Intra-Arterial120122360.030 Why?
Fever1201916170.030 Why?
Xenograft Model Antitumor Assays1201935320.020 Why?
Hepatic Artery120122440.020 Why?
CD8-Positive T-Lymphocytes1202444790.020 Why?
Vaccination1202232800.020 Why?
Bone Marrow1201929460.020 Why?
Biopsy1201967300.020 Why?
Aged420221631370.020 Why?
Cognition1202367540.020 Why?
Incidence12023209380.020 Why?
Middle Aged420222131850.020 Why?
Diagnosis, Differential12019129500.010 Why?
Mice22019809990.010 Why?
Cell Differentiation12019114640.010 Why?
Male420223497710.010 Why?
Animals220191684340.010 Why?
Female320223798750.010 Why?
Young Adult12019564100.010 Why?
Adolescent12019857570.010 Why?
Aged, 80 and over12012577390.000 Why?
Leick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (107)
Explore
_
Co-Authors (74)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.